Legal Opinion
United States ex rel. Bilotta v. Novartis Pharmaceuticals Corp.
District Court, S.D. New York
Decided September 30, 2014No. 11 Civ. 007(PGG)PublishedCited by 40 opinions
1Opinion of the Court
MEMORANDUM OPINION & ORDER
PAUL G. GARDEPHE, District Judge:
In this qui tarn action, Relator Oswald Bilotta alleges that Defendant Novartis Pharmaceuticals Corporation (“Novartis”) violated the False Claims Act (“FCA”), 31 U.S.C. §§ 3729(a)(l)(A)-(B) and related state laws by (1) causing false claims for reimbursement for patient prescriptions— that were written in exchange for kickbacks in violation of the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b and related state laws — to be submitted to federal and state health care programs (“the kickback claims”); and (2) promoting the drug Val-turna…
2Cases cited85 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Carnegie-Mellon University v. CohillSupreme Court of the United States · 1988
- Lugosch v. Pyramid Co. of OnondagaCourt of Appeals for the Second Circuit · 2006
- Chambers v. Time Warner, Inc.Court of Appeals for the Second Circuit · 2002
80 more not listed; retrieve them via the Exa API.
3Cited by40 opinions
- Greene v. Gerber Products Co.District Court, E.D. New York · 2017
- Daniel v. Mondelez Int'l, Inc.District Court, E.D. New York · 2018
- Jones-McNamara v. Holzer Health SystemsCourt of Appeals for the Sixth Circuit · 2015
- Kane v. Healthfirst, Inc.District Court, S.D. New York · 2015
- Trisvan v. HeymanDistrict Court, E.D. New York · 2018
35 more not listed; retrieve them via the Exa API.